Prevalence of COPD in rural population, Muzaffarnagar by Chaturvedi, Rahul et al.
INDIAN JOURNAL OF COMMUNITY HEALTH / VOL 27 / ISSUE NO 04 / OCT – DEC 2015                                                [Prevalence of COPD…] | Chaturvedi R et al 
467 
ORIGINAL ARTICLE 
Prevalence of COPD in rural population, Muzaffarnagar 
Rahul Chaturvedi1, Khursheed Muzammil2, Nirankar Singh3, Sanjeev Davey4, Jai Veer Singh5 
1Post Graduate 3rd Year, 2,3Professor, 4Assistant Professor, 5Professor and Head, Department Community 
Medicine, Muzaffarnagar Medical College, Muzaffarnagar, Uttar Pradesh-251203, India 
Abstract Introduction Methodology Results Conclusion References Citation Tables / Figures 
Corresponding Author 
Address for Correspondence: Dr Rahul Chaturvedi, PG resident, Department of Community Medicine, 
Muzaffarnagar Medical College, Muzaffarnagar, Uttar Pradesh-251203, India 
E Mail ID: dr.rahulchaturvedi@gmail.com  
Citation 
Chaturvedi R, Muzammil K, Singh N, Davey S, Singh JV. Prevalence of COPD in rural population, Muzaffarnagar. 
Indian J Comm Health. 2015; 27, 4: 467-471. 
Source of Funding: Nil Conflict of Interest: None declared 
Article Cycle  
Submission: 30/08/2015; Revision: 20/09/2015; Acceptance: 15/12/2015; Publication: 31/12/2015 
Abstract 
Background: Chronic Obstructive Pulmonary Disease (COPD) is a life-threatening lung disease that interferes with 
normal breathing – it is more than a “smoker’s cough”. Recently, Chronic Obstructive Pulmonary Disease (COPD) 
has gained interest as a major public health concern and is currently the focus of intense research because of its 
persistently increasing prevalence, mortality, and disease burden in countries of high, middle and low income. 
Objective: 1) To asess the prevalence of COPD in 30 years and above in rural catchment of bilaspur which is field 
practice area of MMC. 2) To study the risk factors associated with COPD in a Study population Material and 
Methods: Study Area: The study was conducted in catchment area of Rural Health Training Center, which is a field 
practice area of the department of community medicine, Muzaffarnagar Medical college, Muzaffarnagar, having  
1323 registered families with population of 1425. Study design: cross-sectional Study period: carried out between 
1st April 2014 to 31st March 2015. Results: In the present study, the symptoms of chronic bronchitis were reported 
by 71 (7.8%) subjects. Out of these only 62 had an airflow limitation based on low FEV1/FVC ratio on spirometry. 
Conclusion The present study also showed that bidi smoking was more prevalent in the economically 
underprivileged and those with low educational status due to affordability factor. Bidi smoking was more harmful 
than cigarette smoking in causation of COPD in the present study. Smoking anytime in life increased the chances 
of COPD 13 folds 
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Introduction  
Chronic obstructive pulmonary disease (COPD) is a 
lung ailment that is characterized by a persistent 
blockage of airflow from the lungs. It is an under-
diagnosed, life-threatening lung disease that 
interferes with normal breathing and is not fully 
reversible. The more familiar terms of chronic 
bronchitis and emphysema are no longer used; they 
are now included within the COPD. (1) Chronic 
obstructive pulmonary disease (COPD) is a 
preventable and treatable disease state 
characterized by airflow limitation that is not fully 
reversible. Chronic bronchitis is defined clinically as 
chronic productive cough for 3 months in each of 2 
successive years in a patient in whom other causes 
of productive chronic cough have been excluded. (2) 
Emphysema is defined pathologically as the 
presence of permanent enlargement of the airspaces 
distal to the terminal bronchioles, accompanied by 
destruction of their walls and without obvious 
fibrosis. (3) In patients with COPD either of those 
conditions may be present. Asthma differs from 
COPD in its pathogenic and therapeutic response, 
and should therefore be considered a different 
clinical entity (3). 
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Global Burden of COPD: In 2001, COPD was the fifth 
leading in cause of death in high income countries 
accounting for 3.8% of the total deaths and it was the 
sixth leading cause of death in the nations of low and 
middle income, accounting for 4.9% of the total 
deaths. Overall COPD was responsible for 4.8% of 
total deaths in the world in 2001. (4) It is expected to 
be the third leading cause of death worldwide by 
2020. (5,6) The Global Burden of Disease Study 
estimated that in 1990, the worldwide prevalence of 
COPD was 9.34 per 1000 males and 7.33 per 1000 
females. (7,8) In 1994, there were more than 52 
million individuals around the world suffering from 
COPD. 
Social and economic impact of COPD: It is projected 
to be the fifth leading cause of DALYS by 2020 
accounting for 57.6 million DALYS worldwide and 
52.7 million DALYs in developing regions. (9) In the 
European Union, the total direct costs of COPD 
accounts to about 38.6 billion Euros. (10) In the 
United States in 2002, the direct costs of COPD were 
$ 14.1 billion. (11) 
Burden of COPD in India: COPD is a major cause of 
morbidity and mortality in India too. In a recent 2005 
estimate in India. Chronic respiratory disease was 
shown to account for 7% of deaths and 3% of DALYs 
lost. (12) In a review of different Indian studies the 
total burden due to COPD was calculated to be 8.15 
million male and 4.21 million female patients in a 
population of 944.5 million in 1996. (13) In most non 
TB chest clinics COPD constitutes 25-30% of the 
cases. The prevalence in general population varies 
widely from 1% in urban non-smokers to 21% of the 
rural smokers. (14,15)  
Health planners need to get ready to face a caseload 
of about 222.16 lakh COPD in 2016 a majority of 
which would be from rural areas where the poverty 
levels are high. (16) 
Aims & Objectives 
1. To assess the prevalence of COPD in 30 years and 
above population in rural catchment of Bilaspur 
which is a field practice area of Muzaffarnagar 
Medical College. 
2. To identify the risk factors associated with COPD 
in the study population 
Material and Methods 
In rural areas of Muzaffarnagar bidi smoking has 
emerged as an important factor for causation of 
COPD. Therefore, for estimating the prevalence of 
COPD and risk factors associated with it, simple 
random sampling was applied in the population. 
The study was done with following methods: Study 
Area: The study was conducted in catchment area of 
Rural Health Training Center, which is a field practice 
area of the department of community medicine, 
Muzaffarnagar Medical college, Muzaffarnagar, 
having 1323 registered families with population of 
14250. Study Subjects: Comprised with people of 30 
years and above. Study Design: Cross-sectional. 
Study Period: Carried out between 1st April 2014 to 
31st March 2015. 
The following inclusion and exclusion criteria was 
adopted in study: 
Inclusion criteria 
1. People (males and females) residing for at least 
3 year in above mentioned area. 
2. Aged 30 years and above. 
3. People who gave informed consent. 
4. People found fit for performing spirometry. 
Exclusion criteria 
1. People who were documented cases of other 
chronic respiratory illnesses like bronchiectasis, 
cystic fibrosis. 
2. People who did not give informed consent. 
Enrollment: people residing in the above area and 
meeting the above inclusion criteria were enrolled in 
the study. 
Sampling: Simple random sampling 
Sample size: The sample size for the study was 900 
patients. This was based on the assumptions i.e. 10% 
people were suffering from COPD in the population, 
with 20% permissible error and level of significance 
5%(α) 
Formula used: n= 4PQ/L2 
Where P= proportion of people having COPD, 
Q=(100-P), L= affordable error (20% of p) 
n= 4*10*(100-10)/2*2 =900 
Methodology: 
a. A house to house survey was conducted in all the 
registered families of rural field practice area of 
department of community medicine 
Muzaffarnagar Medical college and hospital 
Muzaffarnagar. 
b. Listing of household having people 30 years of 
age and above was done in order to select the 
study subject from the list prepared. The first 
household was selected randomly by lottery 
method to start with, after that next household 
was selected on alternate basis till the desired 
sample size was achieved 
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C) CLASSIFICATION OF SEVERITY OF COPD5 
Stage  FEV1 /FVC ratio Post bronchodilator FEV1 
0: At risk Normal spirometry --- 
1: mild COPD <70% ≥ 80% predicted 
2: Moderate COPD <70% 50% ≤ FEV1  <80% predicted 
3: Severe COPD <70% 30%≤ FEV1  <50% predicted 
4: Very severe COPD <70% FEV1  < 30% predicted 
Results 
The study was conducted by house-to-house survey 
in Bilaspur village, the rural field practice area of 
Community Medicine Muzaffarnagar Medical 
college Muzaffarnagar UP. A total of 1011 subjects 
were contacted during the study period. 73 subjects 
declined to give consent for the study and were 
excluded accordingly. Out of 938 (92.7%) subjects 
who were studied, 30 subjects could not perform 
spirometry and were excluded from the final 
analysis. Hence the final sample consisted of 908 
subjects. 
The maximum number of subjects belonged to the 
age group of 30-40 Years (35.7%) followed by 40-50 
years (29.6%). The age group 70 and above years 
constituted only 4.7% of the population. The age 
ranged from 30 to 90 years (range 60 years). Mean 
age of the subjects was 44.88 ± 11.7 years. The study 
subjects were almost equally distributed with 
respect to their gender with males comprising 51.8% 
of the sample and females 48.2%. (Table 1) 
The prevalence of COPD increased with increasing 
age of the subjects. Only 3.4 % of subjects in age 
group 30-40 years had COPD which increased to 
13.6% in 60-70 years and 20.9% in 70 years and 
above. Maximum number of COPD cases were seen 
in those 50 years and above subjects with an 
estimated prevalence of 13.3%. A significant 
association (p<0.001) was seen between increasing 
age and prevalence of COPD. (Table 2) 
Majority of cases of COPD were seen in lower 
socioeconomic class with the prevalence being 
11.36% and 7.0% in Class V and Class IV 
socioeconomic class respectively. 5.26% in Class III 
had COPD 15.38% and 3 10.0% cases were seen in 
Class I and class II. There was no significant 
association of COPD with socioeconomic status 
(P>0.05) (Table 3) 
COPD was diagnosed in 24.5% of the currently 
smoking subjects in comparison to only 2.5% in 
nonsmokers. This was found to be higher in females 
(37.5%) than males (21.3%). There was no statistical 
significance in gender-wise prevalence of COPD in 
currently smoking subjects. However current 
smoking was significantly associated with COPD in 
both sexes (p<0.01). (Table 4) 
The overall prevalence of COPD was 11.9% in ex-
smokers in comparison to only 1.3% in the never 
smokers. This was higher in males (14.3%) as 
compared to females (7.1%). Smoking in the past 
was significantly associated with COPD in both males 
(p<0.001) and females (p<0.01). There was no 
statistical difference in gender-wise occurrence of 
COPD in ex-smokers (Table 5) 
20.8% reported smoking bidi and 2.7% cigarette 
anytime in life out of total population. The 
prevalence of COPD was found to be 36.0% and 
15.6% in exclusive cigarette and bidi smokers 
respectively. No case was found in 4 exclusive 
hookah smokers. Those smoking a combination of 
bidi, cigarette or hookah had a prevalence (14.7%) 
lower than those smoking either form exclusively. 
The association between COPD and type of smoking 
was significant (p<0.01) (Table 6) 
Discussion 
In studies conducted by Malik et al (15) and Jindal et al 
(14) in North India the diagnosis was based on clinical 
assessment. Objective assessment of the airflow 
obstruction by measuring the peak expiratory flow rate 
(PEFR) done in Studies by Malik et al (15) and Jindal et al 
(14). In a review of different population based studies (13-
15) from India, SK Jindal et al found that prevalence rates 
in above 30 years population in male subjects varied from 
2.1% to 9.4% in studies from North India and 1.4% to 4.1% 
in studies from South India. The respective figures for 
females were 1.3% to 4.9% in North India and 2.5% to 
2.7% in South India. Assessment of airflow limitation by 
spirometry has not been reported in a general population 
survey in India The current study was a community based 
cross sectional study undertaken with the objectives to 
study the prevalence of chronic obstructive pulmonary 
disease (COPD) among population 30 years and above and 
to identify the risk factors associated with the disease in 
the study population. The study also tried to investigate 
the treatment seeking behavior in those patients who 
were suffering from the disease. The study was carried out 
in RHTC bilaspur which is a field practice area of 
Muzaffarnagar medical college for a period of 12 months 
through a house to house survey. Muzaffarnagar being an 
industrial area is surrounded by various industries like Iron 
casting, sugar mills, copper industry, paper mill chances of 
exposure to harmful heavy metals are high and 
contributed significantly in causing disease in people 
residing nearby bilaspur village of district Muzaffarnagar 
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Conclusion 
From the total population a total of 908 subjects 
were observed and study was carried out on them 
COPD prevalence came out 7.49% and it was almost 
twice more common in males than females. 
The present study also showed that bidi smoking was 
more prevalent in the economically underprivileged 
and those with low educational status due to 
affordability factor. Bidi smoking was more harmful 
than cigarette smoking in causation of COPD in the 
present study. Smoking anytime in life increased the 
chances of COPD up to 13 folds. The risk of 
occurrence was directly related to the total amount 
of exposure to the tobacco smoke i.e. the total 
number of bidis or cigarettes smoked per day and 
duration of smoking. This was found to be an 
independent risk factor, even after adjusting for 
other factors. It is recommended to have a screening 
programme for the elderly above age of 60 years 
with special focus on those exposed to risk factors to 
diagnose the disease at the earliest and initiate 
appropriate management. 
Recommendation 
Bidi being more harmful than cigarette, it is time to relook 
at some of the tobacco control policies. While the 
cigarette packets carry a statuary warning about their 
harmful effects, bidi packs do not carry any such warning. 
So it is recommended to make necessary provisions to 
highlight the potential hazards of bidi smoking to the 
consumers. Also to make these warning on the packets to 
be more explicit for the illiterate and underprivileged 
people specifically designed health education 
programmes aimed at reducing the smoking habit should 
be focused in underprivileged populations and people 
with low educational status. 
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Tables 
TABLE 1 DISTRIBUTION OF STUDY SUBJECTS BY AGE AND SEX (N=908) 
 
TABLE 2 AGE SPECIFIC PREVALENCE OF COPD IN THE STUDY SUBJECTS (N=908) 
AGE N(908) NO OF PATIENT WITH COPD NO OF PATIENT WITHOUT COPD PREVALANCE OF COPD 
30-40 324 11 313 3.4% 
40-50 269 14 255 5.2% 
50-60 147 17 130 11.6% 
60-70 125 17 108 13.6% 
70& ABOVE 43 9 34 20.9% 
TOTAL 908 68 840 7.5% 
X2=31.53 at DF =4 The P value is<0.000001. The result is significant at p<0.01 
 
TABLE 3 PREVALENCE OF COPD ACCORDING TO THE SOCIOECONOMIC STATUS (N=908) 
SOCIAL CLASS* N = (908) NO.OF PT. WITH COPD NO OF PT. WITHOUT COPD  PREVALANCE OF COPD (%) 
I 13 2 11 15.4 
II 30 3 27 10.0 
III 190 10 180 5.3 
IV 543 38 505 7.0 
V 132 15 117 11.4 
X2=4.78 at DF= 4. The P value is 0.310625.p>0.05 
 
TABLE 4 PREVALENCE OF COPD IN CURRENTLY SMOKING SUBJECTS 
CURRENTLY SMOKING N(908) NO OF PT WITH COPD NO OF PT WITHOUT COPD PREVALANCE OF COPD( %) 
YES 204 50 154 24.51 
NO 704 18 686 2.56 
TOTAL 908 68 840 7.49 
X2=47.64 at DF =1. The P-value is <0.00001. The result is significant at p<0.01 
 
TABLE 5 GENDER-WISE PREVALENCE OF COPD IN EX-SMOKERS 
X2=19.33 at DF=1The P- value is 1.3. The result is significant at p<.01 
 
TABLE 6 PREVALENCE OF COPD WITH RESPECT TO THE TYPE OF SMOKING HABIT (N=908) 
TYPE OF SMOKING HABBIT N(908) NO OF PT WITH COPD NO OF PT WITHOUT COPD PREVALANCE OF COPD 
NO EXPOSURE 552 8 544 1.4 
CIGARETTE 25 9 16 36 
BIDI 256 40 216 15.6 
MIXED 75 11 64 14.7 
TOTAL 908 68 840 7.5 
 
 MALE  FEMALE  TOTAL PERCENTAGE 
DOMAIN 470 51.8% 438 48.2% 908  
AGE CATEGORIES 
30-40 167 35.5 157 35.8 324 35.7 
40-50 135 28.7 134 30.7 269 29.6 
50-60 67 14.3 80 18.2 147 16.2 
60-70 67 14.3 58 13.3 125 13.8 
70 & ABOVE 34 7.2 9 2.1 43 4.7 













PREVALANCE OF COPD 
(%) 
YES 56 8 48 28 2 26 84 10 11.9 
NO 250 3 247 370 5 365 620 8 1.3 
TOTAL 306 11 295 398 7 391 704 18 2.6 
